top of page
Search Results

996 items found for "GPCR Drug Design"

Programs (7)

View All

Posts (554)

  • Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs

    GPCRs continue to be regarded as one of the most tractable classes of drug targets and are targeted by 30%–40% of current drugs (Hauser et al., 2017), with annual sales of GPCR-targeting drugs in 2018 accounting Despite this high number of GPCR targeted drugs, only a small portion (∼110) of the human GPCRome (consisting of approximately 850 GPCRs) has been successfully drugged, and obtaining highly potent and selective Read more at the source #DrGPCR #GPCR #IndustryNews

  • Verily links up with Sosei Heptares for GPCR drug discovery

    drugs in treating a range of health conditions, from cancer and genetic disorders to inflammation and to that star are Verily and Sosei Heptares, which have struck a research agreement to discover new GPCR targets that’ll fuel the development of potential drug candidates. drug discovery have clocked in at $1 billion—with Genentech—and, just last November, $2.6 billion in Read more at the source #DrGPCR #GPCR #IndustryNews

  • Artificial intelligence – faster, smarter, cheaper GPCR drug discovery

    of novel drugs, optimize drug design processes, and enhance the understanding of GPCR biology. De novo drug design: AI algorithms can generate new molecules with desired properties, such as binding Multi-target drug design: GPCRs are often involved in complex signaling networks. With the revolution of biased signalling of GPCRs comes the possibility of designing drugs that selectively the process, optimizing drug design, and improving success rates.

View All

Other Pages (434)

  • 21-06 Dr GPCR Newsletter

    GPCR news. Dr. function Evolving cryo-EM structural approaches for GPCR drug discovery Correlated Motions of Conserved inhibition Structure-guided Design of G Protein-coupled Receptor Polypharmacology Aging-associated deficit Sosei Heptares announces that the third novel drug candidate from its multi-target drug discovery collaboration Drug Design, June 22, 2021 4.

  • Principles of Pharmacology in Drug Discovery II

    utilization in drug therapy . be exploited for new drug discovery. New ligands and new GPCR behaviors that produce unique drug profiles (i.e. intracellular ligands and Lecture 3: The Application of GPCR Ligand Kinetics to Candidate Design. Lecture 4: Unconventional GPCR Ligands as Drugs.

  • Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia

    < GPCR News < GPCRs in Oncology and Immunology Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Experimental design: We performed targeted sequencing, high-throughput drug screening, and single-cell to some drug classes, such as MEK inhibitors for RAS-mutated leukemia. GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs

View All